[go: up one dir, main page]

TW200706173A - Oral composition comprising carbamylating agent - Google Patents

Oral composition comprising carbamylating agent

Info

Publication number
TW200706173A
TW200706173A TW094126807A TW94126807A TW200706173A TW 200706173 A TW200706173 A TW 200706173A TW 094126807 A TW094126807 A TW 094126807A TW 94126807 A TW94126807 A TW 94126807A TW 200706173 A TW200706173 A TW 200706173A
Authority
TW
Taiwan
Prior art keywords
oral composition
carbamylating agent
agent
carbamylating
diluent
Prior art date
Application number
TW094126807A
Other languages
Chinese (zh)
Inventor
Jekone Zsuzsanna Bentzik
Sabine Gutman
Original Assignee
Icn Dutch Holdings Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Dutch Holdings Bv filed Critical Icn Dutch Holdings Bv
Publication of TW200706173A publication Critical patent/TW200706173A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to fast release oral compositions containing a carbamylating agent, such as pyridostigmine bromide, a hydrophobic agent and a diluent, and methods of administering and preparing such compositions.
TW094126807A 2004-06-30 2005-08-08 Oral composition comprising carbamylating agent TW200706173A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58434904P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
TW200706173A true TW200706173A (en) 2007-02-16

Family

ID=35783388

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094126807A TW200706173A (en) 2004-06-30 2005-08-08 Oral composition comprising carbamylating agent

Country Status (2)

Country Link
TW (1) TW200706173A (en)
WO (1) WO2006005017A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2356984A1 (en) * 2010-02-04 2011-08-17 Nycomed Austria GmbH Improved distigmine bromide formulation
CA3071377C (en) 2017-01-09 2021-11-30 Kathleen E. Clarence-Smith Compositions and methods for improving muscle weakness in patients suffering from myasthenia gravis and other myasthenic syndromes
TW201919704A (en) 2017-07-25 2019-06-01 美商Ｇｔ生物製藥公司 Pharmaceutical compositions and methods utilizing PYRIDOSTIGMINE and a NK-1 antagonist for treating myasthenia gravis
WO2019023175A1 (en) 2017-07-25 2019-01-31 Gt Biopharma, Inc. Pharmaceutical compositions and methods utilizing neostigmine and a nk-1 antagonist for treating myasthenia gravis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
WO2006005017A3 (en) 2006-04-20
WO2006005017A2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
MX2009005462A (en) 7,8-saturated-4,5-epoxy-morphinanium analogs.
UA94417C2 (en) 7-substituted aza-indazoles, composition containing same, production method and use thereof
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2009005461A (en) N-oxides of 4,5-epoxy-morphinanium analogs.
MX2007003078A (en) Imidazoquinoline compounds.
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
MX2007005221A (en) Ascomycin crystalline forms and preparation thereof.
AU2003228770A8 (en) Substituted pyrazolopyrimidines
MX2007001035A (en) Method of producing a composition, composition and its use.
TW200738659A (en) Novel compounds
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
TNSN06222A1 (en) Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them
TW200745122A (en) New compounds I
TW200738649A (en) Calcilytic compounds
TW200833371A (en) Process for solid formulations
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
TW200700071A (en) Novel use
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation
MX2007006042A (en) Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof.
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
MX2008001560A (en) Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds.
MXPA03008801A (en) Aryl oxime-piperazines useful as ccr5 antagonists.